Bracco Diagnostics Inc.
Bracco Diagnostics Inc. (United States) is linked to 5 FDA-registered manufacturing sites. 26 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Bracco Diagnostics Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/bracco-diagnostics-inc
Overview
Bracco Diagnostics Inc. is a subsidiary of Bracco Group, an Italian multinational active in the healthcare sector. The company specializes in diagnostic imaging, offering a range of products and solutions for X-ray, MRI, and ultrasound imaging.
Therapeutic areas
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to Bracco Diagnostics Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- BIPSO GmbHSingen (Hohentwiel), Germany · Analytical testing · Drug manufactureSite GMP match
- BRACCO IMAGING SPACOLLERETTO GIACOSA, Italy · Analytical testing · Drug manufactureSite GMP match
- BRACCO IMAGING SPACeriano Laghetto, Italy · API manufactureSite GMP match
- Bracco Suisse SAPlan-les-Ouates, Switzerland · Analytical testing · Drug manufacture
- SPIN S.p.A.Torviscosa, Italy · API manufactureSite GMP match
FDA compliance signals
26 FDA enforcement records linked to this company.
- 4832024-11-27
Failure to develop written procedures
- 4832024-11-27
Late submission of 15-day report
- recall — Class II2018-04-04
Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.
- 4832017-06-05
Late submission of 15-day report
- 4832014-05-30
Failure to develop written procedures
- 4832014-05-30
Written control procedures
- recall — Class III2014-02-19
Failed Stability Testing: This product is below specification for preservative content.
- recall — Class III2013-08-28
Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.
- recall — Class II2013-08-21
Presence of foreign substance: One lot of the product may contain black foreign particles
- 4832013-06-13
Written QA procedures established, followed
- 4832013-06-13
Review of representative number of batches
- 4832013-06-13
Written specifications - components
- 4832013-06-13
Investigations of discrepancies, failures
- 4832013-06-13
Procedures not in writing, fully followed
- 4832013-06-13
input/output verification
- recall — Class II2012-10-03
GMP deviation; Sr-82 levels exceeded alert limit specification
- recall — Class II2012-09-05
Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.
- recall — Class III2012-09-05
Short Fill: The product is being recalled due to a potential underfill of the affected vials.
- 4832012-07-27
Computer control of master formula records
- 4832012-07-27
Investigations of discrepancies, failures
- 4832012-07-27
Procedures not in writing, fully followed
- 4832012-07-27
Review of representative number of batches
- 4832012-07-27
Written QA procedures established, followed
- 4832012-07-27
Written record of complaint to include findings, follow-up
- 4832012-07-27
Written complaint procedures
- warning_letter2012-01-31
FDA Warning Letter (drug product)
Is this Bracco Diagnostics Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.